Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This is a global study to compare the effects of AXA1665, an orally active mixture of amino
acids, compared to placebo, on cognitive and physical function, as well as the safety and
tolerability of AXA1665.